Literature DB >> 10985332

Pharmacokinetic interaction of amprenavir in combination with efavirenz or delavirdine in HIV-infected children.

U Wintergerst1, C Engelhorn, M Kurowski, F Hoffmann, G Notheis, B H Belohradsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10985332     DOI： 10.1097/00002030-200008180-00030

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

Review 1.  Delavirdine: clinical pharmacokinetics and drug interactions.

Authors:  J Q Tran; J G Gerber; B M Kerr
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Amprenavir: a review of its clinical potential in patients with HIV infection.

Authors:  S Noble; K L Goa
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 3.  Delavirdine: a review of its use in HIV infection.

Authors:  L J Scott; C M Perry
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 4.  Antiretroviral pharmacokinetics in the paediatric population: a review.

Authors:  Jennifer R King; David W Kimberlin; Grace M Aldrovandi; Edward P Acosta
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  The role of non-nucleoside reverse transcriptase inhibitors in children with HIV-1 infection.

Authors:  S Maddocks; D Dwyer
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 6.  Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors.

Authors:  P F Smith; R DiCenzo; G D Morse
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 7.  Pharmacokinetics of antiretroviral therapy in HIV-1-infected children.

Authors:  Pieter L A Fraaij; Jeroen J A van Kampen; David M Burger; Ronald de Groot
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

8.  Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers.

Authors:  Ulrik S Justesen; Niels A Klitgaard; Kim Brosen; Court Pedersen
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

9.  Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection.

Authors:  Gene D Morse; Margaret A Fischl; Mark J Shelton; Steve R Cox; Leslie Thompson; Andrew A Della-Coletta; William W Freimuth
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

10.  Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients.

Authors:  Gene D Morse; Susan E Cohn; Mark J Shelton; Carol Greisberger; Steven R Cox; Andrew A Della-Coletta; William W Freimuth; Richard C Reichman
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.